FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Carbamazepine Tablet, Extended Release
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Novartis Pharmaceuticals Corporation (New 10/23/2023)

Company Contact Information:
888-669-6682

Presentation	Posting Date	Related Information
Tablet, Extended Release, 100 mg (NDC 0781-8016-01)	10/23/2023	Novartis Pharmaceuticals’ brand product, Tegretol XR 100 mg (NDC 0078-0510-05), will continue to be manufactured and available.
Tablet, Extended Release, 200 mg (NDC 0781-5987-01)	10/23/2023	Novartis Pharmaceuticals’ brand product, Tegretol XR, 200 mg (NDC 0078-0511-05), will continue to be manufactured and available.
Tablet, Extended Release, 400 mg (NDC 0781-5988-01)	10/23/2023	Novartis Pharmaceuticals’ brand product, Tegretol XR, 400 mg, (NDC 0078-0512-05), will continue to be manufactured and available.